Recently, it was shown that excessive activation of NLRP3 represented a pivotal mechanism in the pathogenesis of metabolic diseases such as type 2 diabetes, obesity, gout, and atherosclerosis [50, 51]. This evidence concerns the gene NLRP3 and atherosclerosis.